Replies to post #65678 on Progressive Care Inc (fka RXMD)

[la_trader]

good to know, thanks- 'First Look' is a low end outfit. it would be good to get rid of them.

R/S will not be needed if they maintain share count and can continue to grow the company purely from sales revenues. in that case I would be ok with a slimmer net margin. it is not an easy path to do that.

that said, if a good earning company needs to R/S for nasdaq listing requirement it is seldom a bad event for stock price. no one is going to dump shares and more than likely the share price will run up.

[golfboy]

Armen is always upbeat , even when he has been working all day .
The last time we spoke , he also told me about the good leads for a M/A and that they have Lic now in Utah and Nev .
Plus them looking at all the possibility's in west palm beach .
Still way under value

[stockforce]

When I spoke to Armen last time, he said institutional investors need to see at least two years audit before they can put their money in. The CEO also mentioned this in her latest interview with SmallCapVoice saying institutional money will come in after 2017 audit.

http://www.otcmarkets.com/stock/RXMD/news/S--Parikh-Mars--CEO-of-Progressive-Care-Inc---Provides-Progress-Report-and-Outlook-for-Investors-in-New-Audio-Interview-at-SmallCapVoice-com?id=179764&b=y

The management has been doing fantastic job since they took control of the company in 2012. Just look at their financials year over year:

http://www.otcmarkets.com/stock/RXMD/financials

2013 net revenue: $9.33M
2014 net revenue: $11.27M
2015 net revenue: $13.64M
2016 net revenue: $18.32M
2017 net revenue: $20.1M

It's unbelievable a $20M QB company with imminent expansions and aggressive M&A plans is still trading under 2 cents. This should be at least 20 cents right now. I have been in this stock since 2015 and have seen every single up and down of the stock price. But one thing has not changed a bit: The management's unyielding devotion to the company's business development and their sincere care about shareholders values.

“2017 was a year of accomplishment and we are proud of all that this company has achieved,” stated S. Parikh Mars, CEO. "Reaching $20 million in sales was a challenge this year given the ever changing climate in the healthcare industry. However, we have elevated our level of service and secured our footing for continued growth and expansion in 2018. We now embark on a new set of ambitious goals for the year. Our hard work and dedication will continue to drive us as we prepare for many possible and exciting outcomes.”

Wish all the best to RXMD in 2018. Great things are happening. NSDQ is coming.